Sign up to save your podcasts
Or
Share FDA Issuance on Chloroquine & Hydroxychloroquine for COVID-19
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FDA Issuance on Chloroquine & Hydroxychloroquine for COVID-19
Host: Linda Bernstein, Pharm.D.
The US Food and Drug Administration has authorized clinicians to prescribe chloroquine and hydroxychloroquine for hospitalized patients with COVID-19, despite warnings from scientific advisers that no randomized controlled trial has been conducted to support the drugs’ safety and efficacy in this population. Pharmacist Dr. Linda Bernstein takes us through the FDA’s decision process, the parameters of the issuance, and comments made by the experts on this emergency ruling.
Published April 24, 2020
View all episodes
By ReachMDHost: Linda Bernstein, Pharm.D.
The US Food and Drug Administration has authorized clinicians to prescribe chloroquine and hydroxychloroquine for hospitalized patients with COVID-19, despite warnings from scientific advisers that no randomized controlled trial has been conducted to support the drugs’ safety and efficacy in this population. Pharmacist Dr. Linda Bernstein takes us through the FDA’s decision process, the parameters of the issuance, and comments made by the experts on this emergency ruling.
Published April 24, 2020